GLP-1 Agonists
What Is Retatrutide? A Complete Scientific Overview
Retatrutide is a novel triple GIP/GLP-1/glucagon receptor agonist. Learn about its mechanism of action, clinical trial results, and weight loss potential.
6 min read
Retatrutide is a novel triple GIP/GLP-1/glucagon receptor agonist. Learn about its mechanism of action, clinical trial results, and weight loss potential.
Retatrutide acts on 3 metabolic receptors. -28.7% weight in a trial on 5,800 people. Complete guide to the GLP-1/GIP/Glucagon triple agonist 2026.